FDA Says Chemical with Links to Reproductive Problems Is Safe for Humans

By Ashley Shelby, AlterNet. Posted September 19, 2008.

On September 16, the FDA did something completely expected: it declared the chemical Bisphenol-A (BPA) safe for human consumption. This announcement flies in the face of the overwhelming majority of the scientific literature on this chemical, including the recent and highly-publicized studies out of the National Institutes of Health and a report released this week from the American Medical Association linking BPA and heart disease.

Earlier this year, Canada said it would ban the use of the chemical in baby bottles because its own research showed it leached into formula and breast milk at a level that could affect behavior and the brain in children, as well as reduce survival and birth weight in fetuses (when the chemical was ingested by the mother). In the U.S., the National Toxicology Program, a division of the National Institutes of Health, announced in its draft report that there was "some concern" that BPA could produce the physiological and neurological changes cited by Canada, as well as cancer. California is currently considering a ban on the chemical in baby bottles and food containers. BPA is commonly found in plastics, most notably food containers, including baby bottles. More than 100 government and university studies have found the chemical to be harmful at even low levels; it mimics estrogen (it was, in fact, developed out of the search for a synthetic estrogen), has been linked to increased breast cancer cell growth and disrupted neurodevelopment in fetuses, and is found at detectable levels in the urine of 95 percent of Americans. Newborns and infants seem particularly vulnerable to the chemical.

And yet the FDA has considers the BPA safe. It seems curious, until you consider that the source for the scientific research the agency based this finding on came not from a university or another government research program like the National Toxicology Program. Instead, it came directly from the American Plastics Council, an industry group that represents plastics manufacturers, for whom the use of BPA is a do-or-die proposition. By utilizing only two industry-funded studies on BPA to determine this controversial chemical's safety, particularly in baby bottles, the FDA has finally jumped the shark.

The tortured machinations of the FDA have been documented in great detail over the last eight years: political appointments to top positions within the agency, the hiring of former employees of pharmaceutical companies, making decisions about drugs based on political beliefs, often over the objections of the agency's scientific advisers, and the use, and often exclusive use, of industry research studies to determine whether a product is safe. The New England Journal of Medicine accused the FDA of making "a mockery of the process of evaluating scientific evidence" and that it had "squandered the public trust and tarnished the agency's image." USA Today found that while federal law prohibits the FDA from using experts with staked interest in companies seeking approval, the agency has waived that law nearly a thousand times since 1998. And earlier this year, several members of Congress asked about conflicts of interest at the FDA after the agency's spokesman, who previously worked as a public relations representative for pharmaceutical companies, used agency email to attack the research of an independent scientist who had published a study suggesting diabetes drug Avandia could increase the risk of heart attacks.

See more stories tagged with: plastic, fda, toxic chemicals, baby bottles, bpa, bisphenol-a

Ashley Shelby is a writer based in Minneapolis. Her first book, "Red River Rising: Anatomy of a Flood and the Survival of an American City," was published in April 2004. She blogs at www.scienceforsale.com.

Liked this story? Get top stories in your inbox each week from AlterNet! Sign up now »